STEVEN STONE: Open Payments
NPI 1932480720 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$44,139 in 116 payments from 32 companies in 2025. Trend: 2023 $47,543 · 2024 $46,523 · 2025 $44,139
Speaker / faculty: $27,910Travel & lodging: $7,280Consulting: $6,303Food & beverage: $2,646
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 29 | $18,585 |
| AstraZeneca Pharmaceuticals LP | 19 | $14,349 |
| Novartis Pharmaceuticals Corporation | 13 | $4,067 |
| Amgen Inc. | 5 | $3,671 |
| Janssen Scientific Affairs, LLC | 1 | $1,438 |
| GENZYME CORPORATION | 2 | $520 |
| Alexion Pharmaceuticals, Inc. | 3 | $424 |
| PFIZER INC. | 5 | $224 |
| Janssen Biotech, Inc. | 5 | $103 |
| ABBVIE INC. | 3 | $66 |
Products named: OJJAARA, CALQUENCE, Fabhalta, KYPROLIS, DARZALEX, WAYRILZ, ULTOMIRIS, ELREXFIO.
Industry payments across MI — which companies pay providers there.
